South Korea's SK Biotek Bolsters Investment in APIs
South Korea's SK Biotek Bolsters Investment in APIs
BEIJING--January 24, 2023--Researched by Industrial Info Resources (Sugar Land, Texas)--SK Biotek, one of South Korea's leading pharmaceutical companies, will begin integrating operations from its Yeondong plant in Sejong-si into another plant at the end of March. The move is expected to bolster the company's overall production.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Tennessee Sees $21 Billion Worth of Projects Under Construction
- Indiana Home to $28 Billion in Manufacturing Projects
- Rising Demand for Propylene Spurs Investments in Propane Dehydrogenation Un...
- ISM: U.S. Manufacturing Activity Expands for First Time Since 2022
- South Korea Pioneers Hydrogen Economy with Investments in Fuel Cell Power S...
Quick Links
- Home
- About Us
- Contact Us
- For Traders
Global Market Intelligence
- GMI Database Platform
- GMI Platform Tools
- Industry Coverage
- Analytics & Insights
- Advertising
